Home › Iowa › Bills
Bills

Iowa Congressional Bills

Browse federal bills sponsored by your state's delegation.

Bill results

in committee · Iowa · House Dec 3, 2025

HR 6372: D.C. Shield Law Repeal Act

HR 6372, the D.C. Shield Law Repeal Act, repeals the Human Rights Sanctuary Amendment Act of 2022 (D.C. Law 24-257), which had modified District of Columbia protections for certain immigrant residents. The bill restores the previous legal framework that existed before the 2022 amendment took effect. This directly affects D.C. law and its implementation regarding immigrant rights within the District.
Andrew S. Clyde (R) · 27 co-sponsors
in committee · Iowa · House Dec 3, 2025

HR 4397: Muslim Brotherhood Terrorist Designation Act of 2025

This bill would amend the Anti-Terrorism Act of 1987 to designate the Muslim Brotherhood as a terrorist organization and prohibit its operations within the United States. It would require the President to designate the Muslim Brotherhood as a foreign terrorist organization under immigration law and impose new visa restrictions, including immediate revocation of current visas, for individuals identified as members. The bill mandates annual reports from the Secretary of State identifying Muslim Brotherhood branches worldwide and determining which should be designated as terrorist organizations under existing laws. These provisions would directly affect Muslim Brotherhood members, branches, and affiliated organizations seeking entry to or operating within the United States.
Mario Diaz-Balart (R) · 37 co-sponsors
in committee · Iowa · Senate Dec 2, 2025

SCONRES 24: A concurrent resolution recognizing the 30th anniversary of the Dayton Peace Accords.

This concurrent resolution (SCONRES 24) commemorates the 30th anniversary of the Dayton Peace Accords, signed on December 14, 1995, which ended the Bosnian War. It recognizes the accords' role in halting conflict, ending ethnic cleansing, and establishing peace in Bosnia and Herzegovina, while highlighting Dayton, Ohio's historical role in hosting the negotiations. The resolution reaffirms U.S. support for Bosnia and Herzegovina's sovereignty, EU/NATO partnership, and constitutional reforms, but contains no new laws or direct impacts on any group. As a ceremonial resolution, it does not alter policy or affect any individuals or entities.
Jeanne Shaheen (D) · 6 co-sponsors
in committee · Iowa · Senate Dec 2, 2025

S 3304: Medical Foods and Formulas Access Act of 2025

The Medical Foods and Formulas Access Act of 2025 would require Medicare, Medicaid, CHIP, and the Federal Employees Health Benefits Program to cover medically necessary food for people with specific digestive and metabolic disorders. This includes specialized formulas and nutrients prescribed by healthcare providers for conditions like inherited metabolic disorders, inflammatory bowel disease, and food protein allergies. The bill defines "medically necessary food" to include items such as amino acid preparations, low protein modified foods, and vitamins specifically designed for these conditions, along with necessary medical equipment for administration. Coverage would apply to federal health programs with different effective dates (1-3 years from enactment) and encourages private health insurance plans to provide similar coverage for these life-sustaining treatments.
Roger F. Wicker (R) · 6 co-sponsors
in committee · Iowa · Senate Dec 2, 2025

S 3307: Inspector General Access Act of 2025

This bill reorganizes procedural rules for Inspector General (IG) investigations within the Department of Justice (DOJ). It removes specific language that previously restricted IG access to certain allegations involving DOJ personnel, streamlining the investigation process. The key change eliminates an exception clause in existing law, allowing IGs to investigate all DOJ personnel allegations without that prior limitation. This affects how DOJ investigations are conducted but does not create new policies or change substantive rights. (Procedural bill; summary focuses on specific legal reorganization.)
Richard J. Durbin (D) · 9 co-sponsors
in committee · Iowa · Senate Dec 2, 2025

S 1320: Servicewomen and Veterans Menopause Research Act

This bill requires the Secretaries of Defense and Veterans Affairs to evaluate existing research on menopause, perimenopause, and mid-life health for women serving in the military or who are veterans. It directs them to identify gaps in knowledge about treatments for symptoms, the impact of military service (including combat exposure and toxins like PFAS), and the availability of care and training for healthcare providers. Within 180 days of enactment, the departments must submit a report and strategic plan to Congress detailing findings and outlining steps to address research gaps and improve care. The law directly affects military women, veterans, and their healthcare providers by aiming to enhance understanding and services for menopause-related health issues.
Patty Murray (D) · 10 co-sponsors
in committee · Iowa · House Dec 2, 2025

HR 6358: Veteran Education Empowerment Act

HR 6358, the Veteran Education Empowerment Act, creates a federal grant program to help colleges establish or improve dedicated Student Veteran Centers. These centers provide veterans, active-duty service members, and their families with lounge space, benefits counseling, academic support, and mental health services. Institutions must serve significant numbers of veterans and have sustainability plans to qualify for grants, with funding capped at $500,000 per institution over four years. The bill directly affects colleges serving veterans and aims to address challenges like isolation and transition difficulties through centralized campus support.
Lois Frankel (D) · 42 co-sponsors
in committee · Iowa · House Dec 2, 2025

HR 6143: PRECISE Act

The PRECISE Act amends existing agricultural programs to specifically support farmers adopting precision agriculture practices and technology. It expands eligibility under the Conservation Loan Program (Section 304 of the Farm and Rural Development Act) for loans covering precision agriculture tools like GPS guidance, soil sensors, and data software. Farmers using these loans can also receive increased payments through the Environmental Quality Incentives Program (EQIP), with costs for precision agriculture practices covered up to 90% of expenses. The bill directly affects agricultural producers seeking to improve efficiency, reduce input waste, and enhance environmental outcomes through technology adoption.
Ashley Hinson (R) · 7 co-sponsors
in committee · Iowa · House Dec 2, 2025

HR 5858: CATCH IT Act

The CATCH IT Act (HR 5858) increases federal funding for rural health facilities by raising the federal share of costs for preventative health care equipment by 25 percentage points under the Community Facilities Grant Program. It specifically covers equipment like advanced breast imaging, mobile cancer screening units, cancer screening lab tools, colorectal screening devices, CT scanners, and diagnostic ultrasound equipment. This applies to facilities developing new projects or upgrading existing ones to include these technologies, aiming to improve access to preventative care in rural areas. The policy change takes effect in the first federal fiscal year after the bill is enacted.
Hillary J. Scholten (D) · 2 co-sponsors
in committee · Iowa · House Dec 2, 2025

HR 5710: Bridge the Gap for Rural Communities Act

This bill suspends payment limits for agricultural subsidies for the 2025 crop year, removing caps on payments to farmers. It also establishes a new option for farmers to receive 50% of their expected 2025 crop payments as an advance by December 1, 2025, if they opt in. The remaining balance is paid later after the marketing year ends, with farmers required to repay any overpayment if the final amount exceeds the advance. The bill directly affects farmers growing covered commodities (like corn, soybeans) who choose to participate in the advance payment program.
Eric A. "Rick" Crawford (R) · 31 co-sponsors
in committee · Iowa · House Dec 2, 2025

HR 5598: Revitalizing Rural Communities Act of 2025

This bill increases annual funding for the Rural Economic Development Loan and Grant Program from $10 million to $12 million, effective for fiscal years 2026 through 2030. It directly affects rural communities eligible for loans and grants under this program, which supports local economic development projects. The key mechanism is a specific funding amendment to Section 313B of the Rural Electrification Act of 1936. This change extends and boosts financial resources for rural infrastructure and community initiatives without altering program eligibility or administration.
Zachary Nunn (R) · 5 co-sponsors
passed · Iowa · House Dec 2, 2025

HR 1262: Mikaela Naylon Give Kids a Chance Act

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
Michael T. McCaul (R) · 313 co-sponsors
Showing 529 to 540 of 5,313 bills
Previous 1 … 44 45 46 … 443 Next